Compound index

Small-Molecule Drugs

Omeprazole

FDA-approved for specific indicationsFDA-approved

Last reviewed: 2026-11-19

Evidence status & limitations

Controlled studies support specific acid-related indications; the evidence does not support unrelated general-health claims.

Regulatory status

FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.

  • Prilosec · Acid-related Disorders

    Specified ulcers, reflux-related disease and pathological hypersecretory conditions; populations and combination regimens are label-specific.

    Authoritative label record

Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.

WADA prohibited status: current list and context

Known risks & open questions

Drug interactions and selected infection, electrolyte and long-term exposure concerns are documented.

Key sources

Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.

Related compounds

  • Apomorphine

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Finasteride

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Metformin

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Methylthioninium chloride

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

  • Minoxidil

    Same scientific class · A small chemical molecule, not a peptide. · FDA-approved for specific indications

Related glossary terms